Talk Evidence
Talk Evidence covid-19 update - drop in excess deaths, HIV drugs, academic promotion
03 Jul 2020
In this week's Talk Evidence we're hearing about how the death rate has dropped below average, disappointment about HIV drugs for covid-19 treatment, a trial to reduce polypharmacy, and why academic promotions matter to everyone else. 1.35 - Carl gives us one of his death updates 3.30 - Helen asks if it’s finally time to be able to do the international comparisons we’ve been waiting for? 16.10 - New research suggests that extreme PPE prevents transmission - but PPE came with a whole range of other viral suppression measures, and they all work together. 21.30 - The Recovery trial has said that lopinavir-ritonavir isn’t effective against covid - enough for them to stop the arm of that trial. We talk about this and more treatment evidence. 24.00 - Can a digital intervention reduce poly pharmacy? A new trial on bmj.com says no, but we talk about the composite endpoint and the way the trial is powered. 36.25 - Why academic promotion matters to non academics
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Talk Evidence
Transcribed and ready to explore now
Talk evidence covid-19 update - natural history of covid, include patients in guidelines
09 May 2020
Talk Evidence
Talk Evidence covid-19 update - lack of testing transparency, how to give good debate
04 May 2020
Talk Evidence
Talk Evidence covid-19 update - covid ethics, waste and a minimum RCT size
24 Apr 2020
Talk Evidence
Talk Evidence covid-19 update - Remdesivir, care homes, and death data
17 Apr 2020
Talk Evidence
Talk Evidence covid-19 update - hydroxy/chloroquinine, prognostic models and facemaskss
13 Apr 2020
Talk Evidence
Talk Evidence covid-19 update - pneumonia, guidelines, preprints and testing
09 Apr 2020
Talk Evidence